Seeking Alpha

  Johnson & Johnson (JNJ) - NYSE

  • Alex B. Gray | Send Message 19 Oct 2010

    Johnson & Johnson $JNJ reported Q3 2010 revenues decreased 0.7% to $15B and net earnings increased 2.2% to $3.4B when compared to 2009.
      JNJ vs. ETF Alternatives
      Company Description
      Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the health care field within its Consumer, Pharmaceutical and Medical Devices, and Diagnostics business segments.